Pancreatic Polypeptide (1-17)-(Ala31,Aib32)-Neuropeptide Y (18-3

Product Name
Pancreatic Polypeptide (1-17)-(Ala31, Aib32)-Neuropeptide Y (18-3
Product Quantity
5mg
Catalog Number
LT1992
Molecular Weight
4124.7
Formula
C185H280N54O52S1
Sequence
Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2
Scientific Background

Pancreatic Polypeptide (1-17)-(Ala31, Aib32)-Neuropeptide Y (18-3 is a synthetic research peptide in the neuropeptide Y (NPY) family. Neuropeptide Y is a 36-residue regulatory peptide that signals through the Y-receptor family. Native NPY, C-terminal fragments, substitutions, and constrained analogs are widely used to study Y1/Y2/Y4/Y5 receptor recognition, subtype selectivity, peptide conformation, and receptor activation. Published structure-activity work shows that relatively small sequence changes can markedly alter Y-receptor preference.

Research Applications
  • receptor-binding
  • competition assays
  • functional signaling assays
  • enzymatic-processing or stability studies
  • antibody controls
  • LC-MS/HPLC method development
  • comparative structure-activity experiments
Experimental Notes

For a fragment, residue-substituted analog, stereochemical variant, labeled peptide, or terminally modified form, experimental behavior should be evaluated for the exact construct rather than assumed to match the native parent peptide. Sequence-dependent solubility, aggregation, adsorption, and stability should be considered when selecting reconstitution and assay conditions.

Selected References
  1. Structure-activity Relationship of Novel Pentapeptide Neuropeptide Y Receptor Ligands
  2. Manipulating Y receptor subtype activation of short neuropeptide Y analogs
  • 5 Units in Stock
Ask a Question

$881.28

Add to Cart: